Table 2.
Clinicopathologic characteristics of 86 patients from the literature with reported muscle lymphoma.
| Patients, n | 86 |
| Sex, male/female | 52/34 |
| Age median (range) | 57 (5–90) |
| <18 years | 5 |
|
| |
| Histology | Patients, n (%) |
|
| |
| DLBCL | 61 (70.9) |
| ALCL∗ | 6 (6.9) |
| BL | 4 (4.7) |
| FL | 4 (4.7) |
| PTCL | 4 (4.7) |
| Indolent SBCL, type not specified | 3 (3.5) |
| NK/TCL | 2 (2.3) |
| CLL | 1 (1.2) |
| LBL | 1 (1.2) |
| MCL | 1 (1.2) |
|
| |
| Location | Patients, n (%) |
|
| |
| Lower extremities | 36 (41.9) |
| Upper extremities | 12 (13.9) |
| Back | 8 (9.3) |
| Head/face | 7 (8.1) |
| Shoulder | 7 (8.1) |
| Pelvic | 6 (6.9) |
| Paraspinal | 5 (5.8) |
| Rectal/anal | 5 (5.8) |
| Gluteal | 5 (5.8) |
| Chest | 3 (3.5) |
| Abdominal wall | 2 (2.3) |
| Neck | 2 (2.3) |
ALCL = anaplastic large T-cell lymphoma; BL = Burkitt lymphoma; CLL = chronic lymphocytic leukemia; DLBCL = diffuse large B-cell lymphoma; FL = follicular lymphoma; LBL = lymphoblastic lymphoma; MCL = mantle cell lymphoma; NK/TCL = NK/T-cell lymphoma; PTCL = peripheral T-cell lymphoma; SBCL = small B-cell lymphoma.
∗3 cases with ALK+/2 cases ALK−/1 case ALK not reported.